[1]Yongchun H, Hua J, Xiaohan H, et al.Solutions to stuck tunneled cuffed catheters in patients undergoing maintenance hemodialysis[J].The Journal of Vascular Access, 2021, 22(2):203-208
[2]Rothuizen T C, Wong C, Quax P H, et al.Arteriovenous access failure: more than just intimal hyperplasia?[J].Nephrol Dial Transplant, 2013, 28(5):1085-1092
[3]许倬, 李娇, 张利, 等.代谢组学在慢性肾脏病生物标志物临床研究中的应用[J].中华肾病研究电子杂志, 2018, 7(5):224-230
[4]Meijers B, Evenepoel P, Anders H J.Intestinal microbiome and fitness in kidney disease[J].Nat Rev Nephrol, 2019, 15(9):531-545
[5]Hammes M.Hemodynamic and Biologic Determinates of Arteriovenous Fistula Outcomes in Renal Failure Patients[J]. BioMed research international, 2015, 2015:171674-171677. DOI:10.1155/2015 /171674.[J].BioMed research international, 2015, :171674-171677
[6]Browne L D, Bashar K, Griffin P, et al.The Role of Shear Stress in Arteriovenous Fistula Maturation and Failure:A Systematic Review[J].PloS one, 2015, 10(12):e0145795-
[7]Viecelli A K, Mori T A, Roy-Chaudhury P, et al.The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled[J].Seminars in dialysis, 2018, 31(3):244-257
[8]Salmela B, Hartman J, Peltonen S, et al.Thrombophilia and Arteriovenous Fistula Survival in ESRD[J].Clinical journal of the American Society of Nephrology, 2013, 8(6):962-968
[9]Ma S, Duan S, Liu Y, et al.Intimal Hyperplasia of Arteriovenous Fistula[J]. Ann Vasc Surg, 2022:1–10.DOI:org/10. 1016/j.avsg.2022.04.030.[J].Ann Vasc Surg, 2022, :1-10
[10]Riella M C, Roy-Chaudhury P.Vascular access in haemodialysis: strengthening the Achilles’ heel[J].Nature reviews. Nephrology, 2013, 9(6):348-357
[11]Bilgic M A, Yilmaz H, Bozkurt A, et al.Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula[J].Clin Exp Nephrol, 2015, 19(1):133-139
[12]Lee T, Ul Haq N.New Developments in Our Understanding of Neointimal Hyperplasia[J].Advances in Chronic Kidney Disease, 2015, 22(6):431-437
[13]Pi X, Xie L, Patterson C.Emerging roles of vascular endothelium in metabolic homeostasis[J].Circ Res, 2018, 123(4):47-
[14]Brunet P, Gondouin B, Duval-Sabatier A, et al.Does Uremia Cause Vascular Dysfunction[J].Kidney & blood pressure research, 2011, 34(4):284-290
[15]Lee T, Chauhan V, Krishnamoorthy M, et al.Severe venous neointimal hyperplasia prior to dialysis access surgery[J].Nephrol Dial Transplant, 2011, 26(7):2264-2270
[16]Wasse H, Huang R, Naqvi N, et al.Inflammation,oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients[J].The journal of vascular access, 2012, 13(2):168-174
[17]Weiss M F, Scivittaro V, Anderson J M.Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access[J]. Am J Kidney Dis. 2001, 37:970-980.DOI:10.1053/ajkd.2001. 23618.[J].Am J Kidney Dis, 2001, (37):970-980
[18]Gagnebin Y, Julien B, Belén Pet, et al.Metabolomics in chronic kidney disease: Strategies for extended metabolome coverage[J]. Journal of pharmaceutical and biomedical analysis, 2018, 161:313-325.DOI:10.1016/j.jpba.2018.08.046.[J].Journal of pharmaceutical and biomedical analysis, 2018, (161):313-325
[19]Haggarty J, Burgess K E.Recent advances in liquid and gas chromatography metho-dology for extending coverage of the metabolome. Curr Opin Biotechnol[J], 2017, 43:77-85. DOI:10.1016/j.copbio.2016.09. 006.[J].Curr Opin Biotechnol, 2017, (43):77-85
[20]Hocher B, Adamski J.Metabolomics for clinical use and research in chronic kidney disease[J].Nat Rev Nephrol, 2017, 13(5):269-284
[21]Aron-Wisnewsky J, Clément K.The gut microbiome, diet, and links to cardiometabolic and chronic disorders[J]. Nat Rev Nephrol, 2016; 12(3):169-181. DOI:10.1038/nrneph.2015.191.[J].Nat Rev Nephrol, 2016, 12(3):169-181
[22]Wang X, Yang S, Li S, et al.Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents[J].Gut, 2020, 69(12):2131-2142
[23]Yang T, Richards E M, Pepine C J, et al.The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease[J].Nat Rev Nephrol, 2018, 14(7):442-456
[24]Mika A, Wojtowicz W, Z?bek A, et al.Application of nuclear magnetic resona-nce spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency[J]. Journal of pharmaceutical and biomedical analysis, 2018, 149:1-8. DOI:10.1016/jjp ba.2017.10.037.[J].Journal of pharmaceutical and biomedical analysis, 2018, (149):1-8
[25]Chen D, Cao G, Chen H, et al.Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptop-han[J].Nature Comm- unications, 2019, 10(1):1476-
[26]Wu I W, Hsu K H, Lee C C, et al.p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease[J].Nephrol Dial Transplant, 2011, 26(3):938-947
[27]Koenig P, Nagl C, Neurauter G, et al.Enhanced degradation of tryptophan in patients on hemodialysis[J].Clin Nephrol, 2010, 74(6):465-470
[28]Duranton F, Lundin U, Gayrard N, et al.Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function[J].Clin J Am Soc Nephrol, 2014, 9(1):37-45
[29]Missailidis C, H?llqvist J, Qureshi AR, et al.Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease[J].PloS One, 2016, 11(1):e0141738-
[30]Bain M A, Faull R, Fornasini G, et al.Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis[J].Nephrol Dial Transplant, 2006, 21(5):1300-1304
[31]杜怡, 王玲, 贾洁爽, 等.慢性肾脏病肠道微生态异常致相关代谢产物变化及器官损害[J].中华肾脏病杂志, 2019, 35(2):155-160
[32]Jadoon A, Mathew A V, Byun J, et al.Gut Microbial Product Predicts Cardiovas- cular Risk in Chronic Kidney Disease Patients[J].American journal of nephr- ology, 2018, 48(4):269-277
[33]Yao Y, Cai X, Fei W, et al.The role of short-chain fatty acids in immunity, inflammation and metabolism[J].Crit Rev Food Sci Nutr. 2022, 62(1):1-12.DOI: 10.1080/10408398.2020.1854675.[J].Crit Rev Food Sci Nutr, 2022, 62(1):1-12
[34]Chu L, Zhang K, Zhang Y, et al.Mechanism underlying an elevated serum bile acid level in chronic renal failure patients[J].International urology and nephrology, 2014, 47(2):345-351
[35]Zhu S, Zhang F, Shen A, et al.Metabolomics Evaluation of Patients With Stage 5 Chronic Kidney Disease Before Dialysis, Maintenance Hemod- ialysis, and Peritoneal Dialysis [J]. Frontiers in Physiology, 2021, 11: 630646. DOI:10.3389/fphys.2020.630646.[J]. Frontiers in Physiology, 2021, (11):630-646
[36]Kolachalama V B, Shashar M, Alousi F, et al.Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans[J].Journal of the American Society of Nephrology, 2018, 29(3):1063-1072
[37]Takada T, Yamamoto T, Matsuo H, et al.Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression[J].Scientific reports, 2018, 8(1):11147-11149
[38]Qi X, Zhang Y, Gao J, et al.Metabolite profiling of hemodialysate using gas chromatography time-of-flight mass spectrometry[J].J Pharm Biomed Anal, 2011, 55(5):1142-1147
[39]Gagnebin Y, Jaques D A, Rudaz S, et al.Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics[J].Scientific Reports, 2020, 10(1):19502-
[40]Tsalik E L, Willig L K, Rice B J, et al.Renal systems biology of patients with systemic inflammatory response syndro- me[J].Kidney International, 2015, 88(4):804-814
[41]Sumida K, Kovesdy C P.The gut -kidney-heart axis in chronic kidney disease[J].Physiology international, 2019, 106(3):195-206
[42]Tang W H, Kitai T, Hazen S L.Gut Microbiota in Cardiovascular Health and Disease[J].Circulation Research, 2017, 120(7):1183-1196
[43]Feng Y, Cao G, Chen D, et al.Microbiome–metabolomics reveals gut microbiota associated with glycine- conjugated metabolites and polyamine metabolism in chronic kidney disease[J].Cellular and Molecular Life Sciences, 2019, 76(24):4961-4978
[44]Nigam S K, Bush K T.Uraemic syndrome of chronic kidney disease: altered remote sensing and signallingNature reviews[J].Nephrology, 2019, 15(5):301-316
[45]Li Y, Lu X, Wang J, et al.Metabonomic study of the fruits of Alpinia oxyphylla as an effective treatment for chronic renal injury in rats[J]. Journal of pharma- ceutical and biomedical analysis, 2016, 124:236-245.DOI:10.1016/j.jpba.2016.02.035.[J].Journal of pharma- ceutical and biomedical analysis, 2016, (124):236-245
[46]Günthner T, Jankowski V, Kretschmer A, et al.Endothelium and vascular smooth muscle cells in the context of uremia[J].Seminars in dialysis, 2009, 22(4):428-432
[47]Zhu W, Gregory J C, Org E, et al.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk[J].Cell, 2016, 165(1):111-124
[48] Kalim S, Rhee E P.An overview of renal metabolomics[J]. Kidney Int. 2017 Jan, 91(1):61-69.DOI:10.1016/j.kint.2016. 08.021.[J].Kidney Int, 2017, 91(1):61-69
[49]Altenbuchinger M, Zacharias H U, Solbrig S, et al.A multi-source data integration approach reveals novel associations between metabolites and renal outcomes in the German Chronic Kidney Disease study[J].Scientific Reports, 2019, 9(1):13954-
[50]Li R, Zeng L, Xie S, et al.Targeted metabolomics study of serum bile acid profile in patients with end-stage renal disease undergoing hemodialysis [J].PeerJ, 2019, 7:e7145.DOI:10.7717/peerj.7145.[J].PeerJ, 2019, (7):e7145-
[51]Chen W, Fitzpatrick J, Sozio S M, et al.Identification of Novel Biomarkers and Pathways for Coronary Artery Calcificatio-n in Nondiabetic Patients on Hemodialysis Using Metabolomic Profiling[J].Kidney, 2021, 2(2):279-
